Table 1.
Potential target | Modification site | Major cell types | Biological consequence | Reference |
---|---|---|---|---|
P65 | Cys38 | Macrophage | Inhibiting NF‐κB activity | 33 |
c‐Jun | Cys269 | Macrophage | Attenuating inflammasome activation and IL‐1β production | 34 |
Keap1 | Cys151, Cys226, Cys613 | Fibroblast | Dissociation of Keap1‐Nrf2 complex; antioxidative response | 29, 30 |
PTP1B | Cys215 | 293T cell | Alleviating ER stress | 31 |
PPARγ | Cys139 | Adipocyte | Enhancing DNA binding activity of PPARγ, increasing lipid metabolism | 24 |
NFYB | Cys105 | Regulatory T cell | Promoting the transcription of Tet1/2 | 20, 32 |
Keap1, Kelch‐like ECH‐associated protein 1; NFYB, nuclear transcription factor Y subunit beta; PTP1B, protein tyrosine phosphatase 1B; Tet, tet methylcytosine dioxygenase 2.